Article
[Treatment of hepatitis C virus--2012: a real breakthrough].
Harefuah - 1 Dec 2012
Zuckerman Eli
Abstract excerpt
For almost a decade the standard of care (SOC) therapy in patients with chronic hepatitis C virus (HCV) infection has consisted of a 24-48 week course of pegylated interferon-alpha in combination with ribavirin. This therapy is associated with significant adverse effects and leads to sustained virological response (SVR) in only 50% of patients with genotype 1. The development of compounds with direct antiviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
